Literature DB >> 11833851

Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension.

R Antonicelli1, R Testa, A R Bonfigli, C Sirolla, C Pieri, M Marra, S M Marcovina.   

Abstract

High plasma levels of lipoprotein(a) [Lp(a)] are considered a risk factor for the development of coronary artery disease. In vitro experiments have shown that oxidized Lp(a) is able to impair the arterial endothelium-dependent dilation, thus suggesting a possible role of Lp(a) in the genesis of essential hypertension. The aim of our work was to investigate the correlation of blood pressure levels with plasma Lp(a) concentration, apo(a) isoform size, and peroxidative stress in patients with essential hypertension. The study was performed in 54 untreated hypertensive patients whose blood pressure was monitored for 24 h by ambulatory blood pressure monitoring. Lp(a) concentration was measured by a double monoclonal antibody-based enzyme immunoassay demonstrated to be insensitive to apo(a) size heterogeneity. Apo(a) isoforms were determined by a high-resolution SDS-agarose gel electrophoresis followed by immunoblotting. A significant correlation was found between Lp(a) levels and the night-time systolic and diastolic pressures (r=0.32, P<0.05 and r=0.30, P<0.05, respectively), as well as with the mean night-time fall in systolic and diastolic blood pressures (r=-0.28, P<0.05 and r=-0.29, P<0.05, respectively). These relationships were further potentiated when peroxidative stress data were taken into consideration (r=0.37 and r=0.40, P<0.01 for the night-time systolic and diastolic pressures, respectively and r=-0.34 and r=-0.38, P<0.01 for the night-time fall in systolic and diastolic blood pressures, respectively). Apo(a) isoform size did not affect these relationships. Our data suggest that Lp(a) and peroxidative stress may be involved as cofactors in essential hypertension, with a mechanism that remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11833851     DOI: 10.1007/s10238-001-8026-z

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  9 in total

1.  Insulin resistance explains the relationship between novel cardiovascular risk factors and hypertension. The Telde Study.

Authors:  A M Wägner; J C Wiebe; M Boronat; P Saavedra; D Marrero; F Varillas; F J Nóvoa
Journal:  J Endocrinol Invest       Date:  2010-10-27       Impact factor: 4.256

2.  Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial.

Authors:  Roberta K Oka; Michael S Conte; Christopher D Owens; Joseph Rapp; Gordon Fung; Hugh F Alley; John C Giacomini; Jonathan Myers; Emile R Mohler
Journal:  Vasc Med       Date:  2012-02       Impact factor: 3.239

3.  Serum bilirubin and lipoprotein-a: how are these associated with whole blood viscosity?

Authors:  E U Nwose; R S Richards; P Bwititi; E Butkowski
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 4.  Lipoprotein (a) and Hypertension.

Authors:  Natalie C Ward; Janis M Nolde; Justine Chan; Revathy Carnagarin; Gerald F Watts; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2021-12-09       Impact factor: 5.369

5.  Oral Cholecalciferol Supplementation in Sahara Black People with Chronic Kidney Disease Modulates Cytokine Storm, Oxidative Stress Damage and Athero-Thromboembolic Risk.

Authors:  Houda Zoubiri; Amina Tahar; Samir AitAbderrhmane; Messaoud Saidani; Elhadj-Ahmed Koceir
Journal:  Nutrients       Date:  2022-05-29       Impact factor: 6.706

6.  Lipoprotein (a): More than a bystander in the etiology of hypertension? A study on essential hypertensive patients not yet on treatment.

Authors:  Ali Ghorbani; Mahmoud Rafieian-Kopaei; Hamid Nasri
Journal:  J Nephropathol       Date:  2013-01-01

Review 7.  Biomarkers in hypertension and their relationship with myocardial target-organ damage.

Authors:  Yang Xue; Navaid Iqbal; Jeffrey Chan; Alan Maisel
Journal:  Curr Hypertens Rep       Date:  2014-12       Impact factor: 5.369

8.  Genome-wide association study of nocturnal blood pressure dipping in hypertensive patients.

Authors:  Jenni M Rimpelä; Ilkka H Pörsti; Antti Jula; Terho Lehtimäki; Teemu J Niiranen; Lasse Oikarinen; Kimmo Porthan; Antti Tikkakoski; Juha Virolainen; Kimmo K Kontula; Timo P Hiltunen
Journal:  BMC Med Genet       Date:  2018-07-04       Impact factor: 2.103

9.  Lipid Profile Modulates Cardiometabolic Risk Biomarkers Including Hypertension in People with Type-2 Diabetes: A Focus on Unbalanced Ratio of Plasma Polyunsaturated/Saturated Fatty Acids.

Authors:  Ines Gouaref; Asma Bouazza; Samir Ait Abderrhmane; Elhadj-Ahmed Koceir
Journal:  Molecules       Date:  2020-09-20       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.